R & D

The company carries out research and development works including the development of innovative medicinal products in the field of oncology, leading to the clinical phase I / II.

WPD IL13RA2/EphA2/EphA3 Platform Pipeline

timeline en

Licensing-in 4 clinical stage small-molecule for mono or combo therapy in EU

tab en

R & D